Stay updated on IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Sign up to get notified when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.

Latest updates to the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe NIH banner about terminology updates and related FAQs is no longer displayed; the page still shows a 403 Forbidden message.SummaryDifference1%

- Check20 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide NIH notice announces updates about the transition from “Artificial Intelligence” to “Super Intelligence.” The page itself continues to show a 403 Forbidden error instead of the study record.SummaryDifference1%

- Check34 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check48 days agoChange DetectedThe study record area now displays a 403 Forbidden message with a Home link instead of study details.SummaryDifference0.5%

Stay in the know with updates to IGF-1/IGFBP3 for ROP Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGF-1/IGFBP3 for ROP Prevention Clinical Trial page.